Boston Therapeutics has received its first purchase order of $157,000 for SUGARDOWN from Advance Pharmaceutical a privately-held company based in Hong Kong.
Subscribe to our email newsletter
SUGARDOWN, a non-systemic dietary supplement, is a complex carbohydrate-based chewable tablet to moderate post-meal blood glucose for those concerned about their blood glucose levels.
Boston will manufacture and supply product for Advance Pharmaceutical.
Advance Pharmaceutical will be responsible for the packaging, marketing and distribution of SUGARDOWN in the region.
Boston president Ken Tassey said: "This purchase order is an important milestone in our Asia business development initiative. We believe that Advance Pharmaceutical Trading Co., is an excellent business partner to commercialize SUGARDOWN in Hong Kong."
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.